Revenue
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Orthopediatrics Corp (KIDS)
Price$23.13Cached quote
Net income
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $236.3M | $204.7M | $148.7M | $122.3M | $98.0M | $71.1M | $72.6M | $57.6M | $45.6M | $37.3M | $31.0M |
| Gross profit | $172.7M | $148.6M | $111.3M | $90.7M | $73.4M | $55.0M | $54.6M | $42.7M | $34.5M | $26.4M | $21.6M |
| Gross margin | 73.05% | 72.58% | 74.80% | 74.14% | 74.86% | 77.42% | 75.28% | 74.15% | 75.52% | 70.69% | 69.79% |
| Research & development | $9.1M | $11.0M | $10.9M | $8.5M | $5.5M | $5.3M | $5.7M | $4.7M | $3.4M | $2.2M | $1.8M |
| Operating expenses | $211.9M | $183.6M | $138.0M | $116.1M | $91.4M | $81.8M | $63.7M | $52.2M | $40.9M | $32.5M | $28.2M |
| Operating income | −$39.2M | −$35.0M | −$26.8M | −$25.4M | −$18.0M | −$26.8M | −$9.1M | −$9.6M | −$6.5M | −$6.1M | −$6.6M |
| Operating margin | −16.60% | −17.10% | −17.99% | −20.77% | −18.38% | −37.64% | −12.51% | −16.60% | −14.19% | −16.43% | −21.26% |
| EBITDA | −$18.1M | −$15.9M | −$9.4M | −$12.3M | −$7.3M | −$18.7M | −$4.4M | −$6.7M | −$4.1M | −$4.2M | −$4.7M |
| EBITDA margin | −7.67% | −7.78% | −6.30% | −10.06% | −7.49% | −26.37% | −6.07% | −11.57% | −8.91% | −11.33% | −15.28% |
| Net income | −$39.6M | −$37.8M | −$21.0M | $1.3M | −$16.3M | −$32.9M | −$13.7M | −$12.0M | −$8.9M | −$6.6M | −$7.9M |
| Net profit margin | −16.78% | −18.47% | −14.10% | 1.03% | −16.58% | −46.35% | −18.93% | −20.89% | −19.58% | −17.62% | −25.45% |
| Basic EPSper basic share | -$1.69 | -$1.64 | -$0.92 | $0.06 | -$0.84 | -$1.82 | -$0.94 | -$0.96 | -$5.86 | -$7.14 | -$7.27 |
| Diluted EPSper diluted share | -$1.69 | -$1.64 | -$0.92 | $0.06 | -$0.84 | -$1.82 | -$0.94 | -$0.96 | -$5.86 | -$7.14 | -$7.27 |
Owners
Reported shareholders
≈26.60%of listed shares
Pelizzon David R6.95M shares · Jun 9, 2026
View holders
| Holder | % owned |
|---|---|
Pelizzon David R | ≈26.60%6.95M shares |
BROWN ADVISORY INC | 6.43%1.68M shares |
BlackRock, Inc. | 4.87%1.27M shares |
BRAIDWELL LP | 4.21%1.1M shares |
Granahan Investment Management, LLC | 4.16%1.09M shares |
MILLENNIUM MANAGEMENT LLC | 3.13%816.83K shares |
WELLINGTON MANAGEMENT GROUP LLP | 3.04%794.31K shares |
VANGUARD CAPITAL MANAGEMENT LLC | 2.89%755.62K shares |
Soleus Capital Management, L.P. | 2.80%732.14K shares |
MORGAN STANLEY | 2.66%693.39K shares |
WASATCH ADVISORS LP | 1.97%515.68K shares |
Nantahala Capital Management, LLC | 1.86%484.68K shares |
DIMENSIONAL FUND ADVISORS LP | 1.84%480.85K shares |
GEODE CAPITAL MANAGEMENT, LLC | 1.73%452.35K shares |
Bailey David R | ≈1.60%417.16K shares |
STATE STREET CORP | 1.50%391.63K shares |
CITADEL ADVISORS LLC | 1.28%334.65K shares |
Roubaix Capital, LLC | 1.17%306.56K shares |
GOLDMAN SACHS GROUP INC | 1.17%304.71K shares |
Hite Fred | ≈1.06%277.48K shares |
Percentages use 26.11M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 4 ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Mar 16, 2026Form 4 | Hauser Joseph WPres. Trauma & Def. Correction | SellCommon Stock | 8.6K | $17.25 | $148.3K | 194.8K |
| Mar 16, 2026Form 4 | Hite FredCOO and CFO | SellCommon Stock | 13.0K | $17.25 | $224.1K | 277.5K |
| Mar 16, 2026Form 4 | Bailey David RPresident and CEO | SellCommon Stock | 19.5K | $17.25 | $337.0K | 298.0K |
| Mar 16, 2026Form 4 | Odle Gregory APresident of Scoliosis | SellCommon Stock | 8.4K | $17.25 | $145.5K | 187.7K |
| Mar 16, 2026Form 4 | Gerritzen Daniel JGeneral Counsel and Secretary | SellCommon Stock | 8.6K | $17.25 | $148.6K | 149.5K |